Fingerprint
Dive into the research topics of 'A phase II study of MK-2206, an AKT inhibitor, in uterine serous carcinoma'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
A phase II study of MK-2206, an AKT inhibitor, in uterine serous carcinoma
Elizabeth H. Stover, Niya Xiong, Andrea P. Myers, Nabihah Tayob, Victoria Engvold, Madeline Polak, Russell R. Broaddus, Vicky Makker, Ronny Drapkin, Joyce F. Liu, Neil S. Horowitz, Funda Meric-Bernstam, Carol Aghajanian, Robert L. Coleman, Gordon B. Mills, Lewis C. Cantley, Ursula A. Matulonis, Shannon N. Westin, Panagiotis A. Konstantinopoulos
Research output: Contribution to journal › Article › peer-review
9
Scopus
citations